Exclusive Interview with Director Primary Packaging & Process Development, Boehringer Ingelheim Released Ahead of Injectable Drug Delivery 2021
SMi Reports: SMi Group are delighted to announce Christian Dechant, Director Primary Packaging & Process Development, Boehringer Ingelheim will be speaking at the Injectable Drug Delivery virtual conference taking place in May 2021.
London, United Kingdom, April 28, 2021 --(PR.com)-- In the run up to the conference, Christian Dechant is interviewed by SMi Group to discuss his thoughts on the injectable drug delivery market developing in the future and where do you think the biggest growth area will be going forward.
The brochure with the full agenda and speaker line up for the main conference is available to download www.injectable-drug-delivery.com/prcom5
Snapshot of Christian’s interview:
The injectable drug delivery market has matured greatly over recent years, what key differences have you noticed in the last year regarding significant developments?
“During the last years the patient’s usability has been put more and more in focus. The gained experience in the field of injectable drug delivery helps to integrate patients’ needs to develop the right medication. However, to realize that a lot of flexibility in new technologies and innovations is needed to make it happen that patients from different population can use a medication easily at home.”
“Another key difference is the growing market for biological drugs which often needs a higher drug concentration. This could end in a higher viscosity of the formulation or a not stable molecule and requires large volume devices in the future (>2ml injectable volume). Here the market has to be more innovative to find solutions for large volume injection.”
What current hot topic will you be addressing in your presentation and what would you say makes it relevant to 2021?
“I am addressing the opportunities of silicone oil free pre-filled syringe systems in my presentation. For intravitreal injection or silicone oil sensitive drugs these systems could be a good alternative. If these systems, ensure a reliable functionality for a use in autoinjectors has to be more evaluated!”
Download the full interview and Register online: www.injectable-drug-delivery.com/prcom5
Pharmaceutical and Biotechnology Companies Delegate rate £499 (Limited time only)
applies to pharma and biotech companies only
Commercial rate £999
Proudly sponsored by BD Medical & Owen Mumford
For media queries please contact Jinna Sidhu at hsidhu@smi-online.co.uk or call +44 (0)20 7827 6088
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
The brochure with the full agenda and speaker line up for the main conference is available to download www.injectable-drug-delivery.com/prcom5
Snapshot of Christian’s interview:
The injectable drug delivery market has matured greatly over recent years, what key differences have you noticed in the last year regarding significant developments?
“During the last years the patient’s usability has been put more and more in focus. The gained experience in the field of injectable drug delivery helps to integrate patients’ needs to develop the right medication. However, to realize that a lot of flexibility in new technologies and innovations is needed to make it happen that patients from different population can use a medication easily at home.”
“Another key difference is the growing market for biological drugs which often needs a higher drug concentration. This could end in a higher viscosity of the formulation or a not stable molecule and requires large volume devices in the future (>2ml injectable volume). Here the market has to be more innovative to find solutions for large volume injection.”
What current hot topic will you be addressing in your presentation and what would you say makes it relevant to 2021?
“I am addressing the opportunities of silicone oil free pre-filled syringe systems in my presentation. For intravitreal injection or silicone oil sensitive drugs these systems could be a good alternative. If these systems, ensure a reliable functionality for a use in autoinjectors has to be more evaluated!”
Download the full interview and Register online: www.injectable-drug-delivery.com/prcom5
Pharmaceutical and Biotechnology Companies Delegate rate £499 (Limited time only)
applies to pharma and biotech companies only
Commercial rate £999
Proudly sponsored by BD Medical & Owen Mumford
For media queries please contact Jinna Sidhu at hsidhu@smi-online.co.uk or call +44 (0)20 7827 6088
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Jinna Sidhu
+44 (0) 20 7827 6088
http://www.injectable-drug-delivery.com/prcom5
Jinna Sidhu
+44 (0) 20 7827 6088
http://www.injectable-drug-delivery.com/prcom5
Contact
Categories